The company’s integrated platform assures stable pneumoperitoneum, evacuates smoke and plume when energized medical devices such as electrocautery, laser or ultrasound are used, and provides valve-free access to the abdominal cavity during both laparoscopic and robotic surgical procedures.
SurgiQuest founder and CEO Kurt Azarbarzin said they appreciate the ongoing support that their current and new investors have shown in their technology.
The company will use the capital from the latest round to respond to increasing demand for its products and drive commercialization initiatives domestically and abroad.
